Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matz

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
JAMA|April 29, 1998
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study GroupB Knorr, J Matz, J A Bernstein, et al.
British Journal of Pharmacology|May 26, 2001
Characteristics of the pulse waveform during altered nitric oxide synthesis in the rabbitP D Weinberg, F Habens, M Kengatharan, et al.
Geohealth|February 2, 2026
Health Impact Analysis of Wildfire Smoke-PM<sub>2.5</sub> in Canada (2019-2023)Carlyn J Matz, Marika Egyed, Xihong Wang, et al.
The American Journal of Otology|August 4, 1999
Ototoxicity resulting from combined administration of metronidazole and gentamicinL C Riggs, W P Shofner, A R Shah, et al.
The European Respiratory Journal|September 1, 2001
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsM Solèr, J Matz, R Townley, et al.
The Science of the Total Environment|April 18, 2020
Health impact analysis of PM<sub>2.5</sub> from wildfire smoke in Canada (2013-2015, 2017-2018)Carlyn J Matz, Marika Egyed, Guoliang Xi, et al.
Pain Physician|July 24, 2014
Increased thermal pain sensitivity in animals exposed to chronic high dose Vicodin but not pure hydrocodoneThomas F O'Connell, Patrick S Carpenter, Nadia Caballero, et al.
The European Respiratory Journal|August 9, 2002
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthmaR Buhl, M Solèr, J Matz, et al.
Human Psychopharmacology|March 3, 2010
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidoneM Riedel, R Schennach-Wolff, R Musil, et al.
Pharmacopsychiatry|March 26, 2010
Effect of aripiprazole on cognition in the treatment of patients with schizophreniaM Riedel, I Spellmann, R Schennach-Wolff, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
JAMA|April 29, 1998
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study GroupB Knorr, J Matz, J A Bernstein, et al.
British Journal of Pharmacology|May 26, 2001
Characteristics of the pulse waveform during altered nitric oxide synthesis in the rabbitP D Weinberg, F Habens, M Kengatharan, et al.
Geohealth|February 2, 2026
Health Impact Analysis of Wildfire Smoke-PM<sub>2.5</sub> in Canada (2019-2023)Carlyn J Matz, Marika Egyed, Xihong Wang, et al.
The American Journal of Otology|August 4, 1999
Ototoxicity resulting from combined administration of metronidazole and gentamicinL C Riggs, W P Shofner, A R Shah, et al.
The European Respiratory Journal|September 1, 2001
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsM Solèr, J Matz, R Townley, et al.
The Science of the Total Environment|April 18, 2020
Health impact analysis of PM<sub>2.5</sub> from wildfire smoke in Canada (2013-2015, 2017-2018)Carlyn J Matz, Marika Egyed, Guoliang Xi, et al.
Pain Physician|July 24, 2014
Increased thermal pain sensitivity in animals exposed to chronic high dose Vicodin but not pure hydrocodoneThomas F O'Connell, Patrick S Carpenter, Nadia Caballero, et al.
The European Respiratory Journal|August 9, 2002
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthmaR Buhl, M Solèr, J Matz, et al.
Human Psychopharmacology|March 3, 2010
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidoneM Riedel, R Schennach-Wolff, R Musil, et al.
Pharmacopsychiatry|March 26, 2010
Effect of aripiprazole on cognition in the treatment of patients with schizophreniaM Riedel, I Spellmann, R Schennach-Wolff, et al.
Pageof 11